Stephen Cooper is a former D.C. public defender who worked as an assistant federal public defender in Alabama between 2012 and 2015. He has contributed to numerous magazines and newspapers in the ...

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib) was named Best New Drug at the ...

The Livestock Department has issued an alert over a seasonal rise in Fog Fever, a sudden and severe respiratory disease ...

In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced ...

Although it was pointed out that he and Springbok head coach Rassie Erasmus committed to Munster, before subsequently departing, Nienaber was affronted by questions regarding his loyalty to both the ...

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...

A Tennessee man on death row is scheduled to be executed at 10 a.m. Harold Wayne Nichols, convicted in the 1988 rape and ...

Key points A 62-year-old man with hypertension and chronic renal disease presented to an emergency department with abdominal ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 seconds; Would potentially provide a cost ...

The FDA has granted standard approval to rucaparib (Rubraca) for the treatment of patients with metastatic ...

Malar edema, the collection of fluid below the infraorbital rim and over the malar eminence, presents a unique challenge to ...

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...